Vanguard Fiduciary Trust
EDSA icon

Vanguard Fiduciary Trust’s Edesa Biotech EDSA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
38,718
+272
+0.7% +$2.45K ﹤0.01% 3434
2026
Q1 		$201K Buy
+38,446
New +$115K ﹤0.01% 3520

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust's EDSA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Edesa Biotech (EDSA) stake by 0.71% in Q2 2026, buying an estimated $2.45K and bringing the position to 38,718 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #3434.

Vanguard Fiduciary Trust first reported a position in EDSA in Q1 2026 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Vanguard Fiduciary Trust held 38,718 shares of Edesa Biotech worth $315K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 272 Edesa Biotech shares in Q2 2026, an estimated $2.45K.
  • Edesa Biotech made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3434 holding.
  • Vanguard Fiduciary Trust first reported a position in Edesa Biotech in Q1 2026 and has held it in 2 quarters since.
  • 30 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.